Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ATI-2138 by Aclaris Therapeutics for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
ATI-2138 is under clinical development by Aclaris Therapeutics and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to...
ATI-2138 by Aclaris Therapeutics for Ulcerative Colitis: Likelihood of Approval
ATI-2138 is under clinical development by Aclaris Therapeutics and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...
ATI-2138 by Aclaris Therapeutics for Psoriasis: Likelihood of Approval
ATI-2138 is under clinical development by Aclaris Therapeutics and currently in Phase I for Psoriasis. According to GlobalData, Phase I...